The success story of Profil is largely based on our unique combination of regulatory knowledge and scientific expertise. Profil was founded in 1999 by medical and scientific experts in the fields of diabetes and metabolic disease, and the team of experts at Profil has been growing ever since.
Currently a team of more than 15 consulting experts support our clients in all stages of the development of a new compound. Their area of expertise range from clinical pharmacology (in particular pharmacology of antidiabetic drugs including insulin) over in-depth methodological knowledge (e.g. in stable isotope techniques or cardiovascular assessments) to the fields of nutrition and medical technology.
The collaboration of clients with experts at Profil often starts long before the inclusion of the first patient as our experts have drafted numerous clinical development plans and have defended and discussed these plans in meetings with authorities such as FDA or EMA. In addition, our experts usually prepare the essential documents for the submission of a study at ethics and competent authorities, they help the clinical team with the performance of all important study procedures, assist the sponsor with the interpretation of study results and, if desired, present the clinical trial data at international meetings and publish them in scientific journals.
We enjoy the scientific discussions with our clients as well as the constant active exchange of scientific topics and ideas with top experts from academia, as indicated by joint publications with key opinion leaders e.g. from the Ruhr-Universität Bochum, the Medizinische Hochschule Hannover and the Medical University of Graz, to name only a few. The ideas developed in these discussions often lead to the next study projects and help our clients to take all the aspects into account that are relevant for a successful development and marketing of their compounds.